60 Degrees Pharmaceuticals- Warrants (16/05/2028) Profit Margin

The latest profit margin for SXTPW is -624.69% as of March 2026. That compares with -1566.55% in the prior-year period — up 60.1% year over year. That is below the sector sector average of 19.61%. Investors often review this figure alongside 60 Degrees Pharmaceuticals- Warrants (16/05/2028)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, SXTPW's profit margin moved from -1566.55% to -624.69% — a 60.1% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in 60 Degrees Pharmaceuticals- Warrants (16/05/2028)'s valuation or profitability profile.

Against its sector companies, SXTPW currently prints -624.69% for profit margin, while the sector average sits near 19.61%. That is roughly 3286.1% below the sector mean. Large gaps often invite a closer look at 60 Degrees Pharmaceuticals- Warrants (16/05/2028)'s growth, margins, and balance sheet.

Profit Margin shows how effectively 60 Degrees Pharmaceuticals- Warrants (16/05/2028) converts resources into returns. At -624.69%, SXTPW may look efficient or underperforming depending on peer benchmarks and trend direction. That compares with -1566.55% in the prior-year period — up 60.1% year over year. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting SXTPW's profit margin (-624.69%), review year-over-year change from -1566.55%, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.